NCT06635408View on ClinicalTrials.gov

Cystatin c: a Biomarker of AKI in Aneurysmal Subarachnoid Haemorrhage Patients

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

October 30, 2023

Primary Completion Date

January 1, 2025

Study Completion Date

January 15, 2025

Conditions
Acute Kidney Injury
Interventions
DIAGNOSTIC_TEST

cystatin c

a biomarker to assess renal function

Trial Locations (1)

21648

Faculty of medicine, Alexandria University, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER

NCT06635408 - Cystatin c: a Biomarker of AKI in Aneurysmal Subarachnoid Haemorrhage Patients | Biotech Hunter | Biotech Hunter